• SUBSCRIBE
    • Action Alerts PLUS
    • Real Money
    • Real Money Pro
    • Quant Ratings
    • Retirement Daily
    • Stocks Under $10
    • Trifecta Stocks
    • Top Stocks
    • Real Money Pro Portfolio
    • Chairman's Club
    • Compare All
  • JIM CRAMER
    • Action Alerts PLUS
    • Cramer's Blog
    • Cramer's Monthly Call
    • Jim Cramer's Best Stocks
    • Cramer's Articles
    • Mad Money
    • 25 Rules for Investing
    • 10 Commandments
  • INVESTING
    • Bitcoin
    • Cannabis
    • Cryptocurrency
    • ETFs
    • Earnings
    • Fixed Income
    • Funds
      • Bond Funds
      • Index Funds
      • Mutual Funds
    • Futures
    • Options
    • REITs
    • Stocks
      • Penny Stocks
      • Preferred Stocks
  • PERSONAL FINANCE
    • Credit Cards
    • Debt Management
    • Education
    • Employee Benefits
    • Insurance
      • Car Insurance
      • Disability Insurance
      • Health Insurance
      • Home Insurance
      • Life Insurance
    • Mortgages
    • Real Estate
    • Savings
    • Taxes
  • RETIREMENT
    • 401K
    • Estate Planning
    • IRAs
      • Roth IRAs
    • Social Security
  • TECHNOLOGY
    • Cybersecurity
  • MARKETS
    • Bankruptcy
    • Commodities
      • Gold
      • Oil
    • Corporate Governance
    • Currencies
    • Emerging Markets
    • IPOs
    • Mergers and Acquisitions
    • Rates and Bonds
      • Junk Bonds
      • Treasury Bonds
    • Regulation
  • HOW-TO
  • VIDEO
    • Audio
  • Courses
    • Personal Finance Essentials
    • Fundamentals of Investing
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
  • Privacy Settings
  • Logo
  • JIM CRAMER
  • INVESTING
  • PERSONAL FINANCE
  • RETIREMENT
  • TECHNOLOGY
  • MARKETS
  • HOW-TO
  • VIDEO
  • COURSES
Login
Account
TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
  • Alerts
  • |
  • Newsletters
  • Logo
  • JIM CRAMER
  • INVESTING
  • PERSONAL FINANCE
  • RETIREMENT
  • TECHNOLOGY
  • MARKETS
  • HOW-TO
  • VIDEO
  • COURSES
Login
Account

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

What to Expect When Freeport McMoRan (FCX) Reports First-Quarter Earnings Tomorrow
MARKETS

Jim Cramer Explains How Pfizer's Hospira Acquisition Helps Pharmaceutical Giant

  • By Andrew Meola
  • Feb 5, 2015 1:02 PM EST
Will Amazon.com (AMZN) Stock be Affected by New E-Book Author Royalty Plan?
MARKETS

Dana Holding (DAN) Stock Higher Today Ahead of Joining S&P MidCap 400

  • By Kurumi Fukushima
  • Jan 21, 2015 12:17 PM EST
Today's Weak On High Volume Stock: Ocean Rig UDW (ORIG)
MARKETS

Cubist Pharmaceuticals (CBST) Hits New Lifetime High

  • By Jamie Hodge
  • Jan 21, 2015 9:46 AM EST
3 Hold-Rated Dividend Stocks: GHL, OKS, OAK
MARKETS

Trade-Ideas: Cubist Pharmaceuticals (CBST) Is Today's New Lifetime High Stock

  • By Jamie Hodge
  • Jan 14, 2015 9:46 AM EST
Shire Agrees to Pay $5.2 Billion for NPS Pharmaceuticals
MERGERS AND ACQUISITIONS

Orphan Drug Company NPS Pharmaceuticals May Find Few Buyers

  • By Laura Cooper
  • Jan 6, 2015 5:39 PM EST
Genfit Digs Even Deeper to Find Hidden Benefit in Fatty Liver Drug
STOCKS

Cempra Oral Antibiotic Effective Against Hard-to-Treat Pneumonia

  • By Adam Feuerstein
  • Jan 4, 2015 10:32 PM EST
Stock Market Today - China's Factory Activity Contracted in May as Japan's Expanded
INVESTING

Jim Cramer on the Markets: Some Stocks You Just Can't Ignore

  • By Jim Cramer
  • Dec 23, 2014 10:03 AM EST
3 Basic Materials Stocks Driving The Sector Higher
MARKETS

Cubist Pharmaceuticals (CBST): Today's Pre-Market Leader Stock

  • By David M. Aferiat
  • Dec 22, 2014 8:06 AM EST
Jones Lang LaSalle (JLL) Reaches New Lifetime High Today
MARKETS

Cubist Pharmaceuticals (CBST) Showing Signs Of Being A Momo Momentum Stock

  • By Daniel Mirkin
  • Dec 19, 2014 9:45 AM EST
Gilead Sciences Buying Achillion Was Twitter Speculation at Its Finest
STOCKS

2015 Biotech Drug/Stock Outlook: Here's What You Need to Know

  • By Adam Feuerstein
  • Dec 17, 2014 9:20 AM EST
Health Care Stocks: A Year in Review and Predictions for 2015
OPINION

Health Care Stocks: A Year in Review and Predictions for 2015

  • By Richard Saintvilus
  • Dec 10, 2014 11:38 AM EST
Mobileye Rises After Morgan Stanley, Deutsche Bank Hike Price Targets
INVESTING

Merck May Have Paid $2B-$3B Too Much For Cubist, Analyst Says

  • By The Fly Staff
  • Dec 9, 2014 1:19 PM EST
Weatherford Int'l. (WFT) Stock Sliding Amid Lower Oil Prices
MARKETS

Cubist Pharmaceutical (CBST) Stock Declines Today Following Patent Rejection

  • By Tony Owusu
  • Dec 9, 2014 11:51 AM EST
Jim Cramer on the Stock Market: Thoughts on Merck's Deal for Cubist
INVESTING

Jim Cramer on the Stock Market: Thoughts on Merck's Deal for Cubist

  • By Jim Cramer
  • Dec 9, 2014 10:59 AM EST
Insider Trading Alert - AEL, ANIP And CRM Traded By Insiders
MARKETS

Cubist Pharmaceuticals (CBST) Is Today's Perilous Reversal Stock

  • By Scott Olson
  • Dec 9, 2014 9:47 AM EST
Jim Cramer's Top Stock Picks: AAL SAVE EW MNK KR
OPINION

Jim Cramer's Top Stock Picks: DIS SBUX NKE ENB MRK CRZO

  • By Margo Beller
  • Dec 9, 2014 6:00 AM EST
Jim Cramer's 'Mad Money' Recap: Ignore the Naysayers
JIM CRAMER

Jim Cramer's 'Mad Money' Recap: Why You Should Buy Disney, Starbucks, Nike Now

  • By Bret Kenwell
  • Dec 8, 2014 8:34 PM EST
Stock Markets Grind Higher as Apple Gains on Watch Sales
MARKETS

Stocks Are Dragged Lower as Oil Prices Plunge to 5-Year Low

  • By Keris Alison Lahiff
  • Dec 8, 2014 4:24 PM EST
Stock Markets Grind Higher as Apple Gains on Watch Sales
MARKETS

Stocks Recover From Session Lows Though Oil Prices Continue to Hurt

  • By Keris Alison Lahiff
  • Dec 8, 2014 3:30 PM EST
ConocoPhillips (COP) Stock Gains Today as WTI Crude Rallies in Trading
MARKETS

Why Jim Cramer Likes Merck's Acquisition of Cubist Pharmaceuticals (CBST)

  • By Andrew Meola
  • Dec 8, 2014 3:17 PM EST
Merck (MRK) Stock Closed Higher After Winning Gilead Patents Dispute
OPINION

Merck Seeks Growth Injection, Picks Off Antibiotic Maker Cubist

  • By Richard Saintvilus
  • Dec 8, 2014 2:56 PM EST
Insurance M&A Seen Heating Up, Led By AIG, Ace and Markel
MERGERS AND ACQUISITIONS

Merck to Buy Cubist Pharmaceuticals in $9.5 Billion Deal

  • By Laura Cooper
  • Dec 8, 2014 11:36 AM EST
February 27 Premarket Briefing: 10 Things You Should Know
MARKETS

Stocks Near Flatline as Rally in Pharmaceuticals Overshadows Energy Selloff

  • By Keris Alison Lahiff
  • Dec 8, 2014 11:04 AM EST
Stock Markets Grind Higher as Apple Gains on Watch Sales
MARKETS

Stock Futures Slide as Crude Oil Tumbles Below $65 a Barrel

  • By Keris Alison Lahiff
  • Dec 8, 2014 8:54 AM EST
Will Reports of More Potential Pfizer Acquisitions Affect AbbVie (ABBV) Stock Today?
MARKETS

Cubist Pharmaceuticals (CBST) Stock Skyrockets Today on $8.4 Billion Merck Deal

  • By Tedd Cohen
  • Dec 8, 2014 7:57 AM EST
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2019 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.